PMID- 22230950 OWN - NLM STAT- MEDLINE DCOM- 20120309 LR - 20220330 IS - 1740-1534 (Electronic) IS - 1740-1526 (Print) IS - 1740-1526 (Linking) VI - 10 IP - 2 DP - 2012 Jan 9 TI - Immune reconstitution inflammatory syndrome: the trouble with immunity when you had none. PG - 150-6 LID - 10.1038/nrmicro2712 [doi] AB - Some individuals who are infected with HIV rapidly deteriorate shortly after starting antiretroviral therapy, despite effective viral suppression. This reaction, referred to as immune reconstitution inflammatory syndrome (IRIS), is characterized by tissue-destructive inflammation and arises as CD4(+) T cells re-emerge. It has been proposed that IRIS is caused by a dysregulation of the expanding population of CD4(+) T cells specific for a co-infecting opportunistic pathogen. Here, we argue that IRIS instead results from hyper-responsiveness of the innate immune system to T cell help, a mechanism that may be shared by the many manifestations of IRIS that occur following the reversal of other types of immunosuppression in pathogen-infected hosts. FAU - Barber, Daniel L AU - Barber DL AD - Immunobiology Section, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rm 6146, 50 South Drive, Bethesda, Maryland, 20892, USA. barberd@niaid.nih.gov FAU - Andrade, Bruno B AU - Andrade BB FAU - Sereti, Irini AU - Sereti I FAU - Sher, Alan AU - Sher A LA - eng GR - ZIA AI001171-01/Intramural NIH HHS/United States PT - Research Support, N.I.H., Intramural PT - Review DEP - 20120109 PL - England TA - Nat Rev Microbiol JT - Nature reviews. Microbiology JID - 101190261 RN - 0 (Antibodies, Monoclonal, Humanized) RN - 0 (Natalizumab) SB - IM MH - AIDS-Related Opportunistic Infections/immunology MH - Animals MH - Antibodies, Monoclonal, Humanized/adverse effects/therapeutic use MH - Disease Models, Animal MH - HIV Infections/drug therapy/immunology MH - Humans MH - Immune Reconstitution Inflammatory Syndrome/*etiology/immunology MH - Immune Tolerance/immunology MH - Immunity, Innate/immunology/physiology MH - Lymphopenia/immunology MH - Mice MH - Models, Immunological MH - Multiple Sclerosis/drug therapy/immunology MH - Natalizumab MH - Risk Factors PMC - PMC3507517 MID - NIHMS420386 EDAT- 2012/01/11 06:00 MHDA- 2012/03/10 06:00 PMCR- 2012/11/27 CRDT- 2012/01/11 06:00 PHST- 2012/01/11 06:00 [entrez] PHST- 2012/01/11 06:00 [pubmed] PHST- 2012/03/10 06:00 [medline] PHST- 2012/11/27 00:00 [pmc-release] AID - nrmicro2712 [pii] AID - 10.1038/nrmicro2712 [doi] PST - epublish SO - Nat Rev Microbiol. 2012 Jan 9;10(2):150-6. doi: 10.1038/nrmicro2712.